Home  >  TopNews
Eppen_CellXpert_Mar2026
you can get e-magazine links on WhatsApp. Click here
TopNews
  FDI equity inflow into pharma sector grows 74% in first nine months of FY26,   March 17, 2026
  Top 30 pharma companies post 12% revenue growth in first nine months, net profit up only by 2.8%,   March 13, 2026
  MSN Laboratories expands India’s metabolic care with CDSCO approval for generic semaglutide,   February 27, 2026
  Social media drives nutraceutical consumption driven by influencer-driven marketing: Dr Sunil Chiplunkar,   February 24, 2026
  Revised Schedule M pushes Indian pharma cos to align with international standards: Expert,   February 21, 2026
  201 bulk drugs units set up in Konkan Division of Maharashtra in 10 years,   February 18, 2026
  Indian pharma pivots toward specialty therapeutics and AI-powered drug discovery to reduce timelines & costs,   February 14, 2026
  BDMAI to promote e-Marketing Portal at exhibitions & international markets to enhance global outreach,   February 10, 2026
  Tindivanam Pharma Park in TN hits milestone, cluster ready for manufacturers following CM’s inauguration,   February 09, 2026
  Lalitpur Bulk Drugs Park in UP enters into phase-I with approved DPR and environment clearances,   February 09, 2026
  Pharma associations explore investment opportunities in UP as part of Pharma Conclave 1.0,   February 07, 2026
  Karnal Pharma Park awaits govt nod as Haryana manufacturers urge immediate action,   February 06, 2026
  BDMAI’s e-marketing portal to promote Indian pharma products and services in domestic, global markets,   February 06, 2026
  FDI equity inflow into pharma sector grows to $1.27 billion in H1 FY26,   January 28, 2026
  Experts warn of mass closure of 6,500 pharma MSMEs as revised Schedule M triggers existential crisis,   January 23, 2026
  Zuventus Healthcare refutes closure rumours, cites competitor sabotage,   January 20, 2026
  Amid rising geopolitical tensions, Indian pharma calls for strategic overhaul of supply chain,   January 19, 2026
  ViNS to boost indigenous plasma protein production with Rs. 150 crore investment in PlasmaGen,   January 17, 2026
  GLP-1 innovation & chronic care surge propel Indian pharma to a record Rs. 2.4 lakh crore valuation,   January 15, 2026
  Karnal emerges as potential pharma hub, HPMA demands strategic support for MSMEs,   January 14, 2026

  • Results Found: 1803
  • 1
    •  
  • 2
    •  
  • 3
    •  
  • 4
    •  
  • 5
    •  
  • Go to
  • Total Number of Pages: 91
 Back
 
Propak_Asia_2026
CP_CPHI_Korea2026
IWE_CP_2026
ChemExpo_India_2026
PharmaTech_expo_Chandigarh2026
ASIA_PHARMA_EXPO_2026
CPHI_Japan26
Ana_Lab_India_2026
PharmaCore_India_2026
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram